文献速递生殖医学妇科

围青春期嵌合型特纳综合征卵巢刺激的临床与分子特征

Clinical and molecular features of ovarian stimulation in peripubertal girls with mosaic Turner's syndrome.
PubMed 文献 · Hum Reprod · 2026-01-01

本研究于2021—2023年在一家大学医院及转化研究中心,对4例9、12、13、15岁嵌合型特纳综合征围青春期女孩采用孕激素预处理方案行卵巢刺激取卵冻存,并与卵巢储备正常的成年男性因素不孕对照者比较。结果显示患者均对促性腺激素有反应,颗粒细胞FSH/LH受体表达、类固醇生成酶表达及雌孕激素产生与成年对照相似。

要点

  • 嵌合型特纳综合征围青春期女孩对卵巢刺激有反应,可获取成熟卵母细胞并玻璃化冻存。
  • 其颗粒细胞促性腺激素受体表达与类固醇生成功能与卵巢储备正常的成年女性相似。
  • 证据仅来自4例嵌合型患者,冻存卵母细胞的复苏存活与妊娠结局尚不明确。

核心结论

  • 围青春期嵌合型特纳综合征女孩卵巢刺激的临床与分子生殖/内分泌特征与成年女性相似。
  • 对因卵巢储备下降不适合卵巢组织冻存者,卵巢刺激取卵冻存可能是一种选择。

研究设计与样本

  • 临床与转化研究,2021—2023年在一家大学医院及转化研究中心开展。
  • 纳入4例9、12、13、15岁嵌合型特纳综合征围青春期女孩,对照为卵巢储备正常、因男性因素不孕行卵巢刺激的成年女性。
  • 所有参与者采用孕激素预处理方案,使用重组FSH和LH,以重组hCG诱导最终成熟;取卵时获取黄素化壁层颗粒细胞进行实验。

主要发现

  • 所有特纳综合征病例均对促性腺激素刺激有反应。
  • 9岁青春期前嵌合型病例经4个周期卵巢刺激(r-FSH 300 IU与r-LH 150 IU/日,平均刺激9.72±2.1天)后获9枚成熟卵母细胞并玻璃化冻存。
  • 13岁病例经3轮卵巢刺激获8枚成熟卵母细胞;12岁和15岁病例各仅行1个周期,各获2枚成熟卵母细胞。
  • 患者颗粒细胞FSH/LH受体与类固醇生成酶表达、基础及促性腺激素诱导的类固醇生成酶上调、雌二醇与孕酮产生均与成年对照相似。
  • 共聚焦免疫荧光与活细胞成像显示胆固醇摄取/转运及类固醇生成酶染色模式、与线粒体和载胆固醇脂滴共定位无差异。

临床怎么用

  • 对卵巢储备已下降、不适合卵巢组织冻存的围青春期嵌合型特纳综合征女孩,可考虑卵巢刺激取卵冻存。
  • 刺激方案可采用孕激素预处理联合重组FSH/LH,并以重组hCG诱导成熟。

局限性

  • findings仅来自有限数量的嵌合型特纳综合征患者,是否可外推至非嵌合型围青春期病例尚不明确。
  • 冻存卵母细胞的复苏存活、受精、胚胎发育能力、整倍体状态及产科结局尚无数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do peripubertal girls with mosaic Turner's syndrome (TS) respond to ovarian stimulation (OS) for oocyte freezing as adult women with normal ovarian reserve? SUMMARY ANSWER: Clinical and molecular reproductive/endocrine features of OS in these patients are similar to those of adult females. WHAT IS KNOWN ALREADY: OS for oocyte freezing is quite a new concept in peripubertal and young adolescent girls with TS because ovarian tissue cryopreservation (OTC) does not have proven efficacy, likely due to already diminished ovarian reserve and accelerated follicle atresia. No data are available in the literature regarding the molecular IVF characteristics of these cycles in this group of patients. We aimed to address this issue in the current study by analyzing gonadotropin receptor expression, response to gonadotropins, and steroidogenic function at the molecular level in four peripubertal patients aged 9, 12, 13, and 15 in comparison to control adult females with normal ovarian reserve undergoing OS for male factor infertility. STUDY DESIGN, SIZE, DURATION: This is a clinical and research study that simultaneously analyzes the clinical and molecular characteristics of OS in peripubertal young girls with TS between 2021 and 2023 at a university hospital and translational research center. PARTICIPANTS/MATERIALS, SETTING, METHODS: All participants underwent OS using a progestin-primed protocol with recombinant forms of FSH and LH, and final maturation was induced with recombinant hCG. Control patients who had normal ovarian reserve and underwent OS for male factor infertility were randomly recruited during the study period to simultaneously compare and analyze the clinical and molecular OS characteristics of the peripubertal TS cases. Luteinized mural granulosa cells obtained during oocyte retrieval procedures were used for the experiments. Cell culture, quantitative real-time PCR, immunoblotting, confocal time-lapse live-cell imaging, and hormone assays were used. MAIN RESULTS AND THE ROLE OF CHANCE: All TS cases responded to gonadotropin stimulation. Nine mature oocytes were retrieved and vitrified in the 9-year-old prepubertal mosaic TS case after four cycles of OS with r-FSH (300 IU) and r-LH (150 IU)/day after a mean stimulation period of 9.72 ± 2.1 days. Eight mature oocytes were retrieved in the case aged 13 after three rounds of OS. The other cases, aged 12 and 15, underwent only one cycle of OS, and two mature oocytes from each were retrieved. The expression of FSH/LH receptors and steroidogenic enzymes, basal and gonadotropin-induced up-regulation in the expression of the steroidogenic enzymes, and estradiol and progesterone productions of the GCs of the TS patients were similar to those of adult control patients. Confocal immunofluorescence microscopy and live imaging revealed no differences in cholesterol uptake/trafficking or in staining patterns of the steroidogenic enzymes and their co-localization with mitochondria and cholesterol-laden lipid droplets. LIMITATIONS, REASONS FOR CAUTION: Findings were obtained from a limited number of mosaic TS patients. It is unclear if these findings are reproducible in non-mosaic peripubertal cases. Furthermore, no data are available yet regarding the post-thaw survival, fertilization, embryo development competency, euploidy status, and obstetrical outcomes of the vitrified oocytes of these patients. WIDER IMPLICATIONS OF THE FINDINGS: This study provides reassuring clinical and molecular evidence that OS for oocyte freezing can be an option in young girls with mosaic TS who are not ideal candidates for OTC due to diminished ovarian reserve. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the School of Medicine, the Graduate School of Health Sciences, and the Research Center for Translational Medicine (KUTTAM) at Koç University. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Oktem O, Kalajahi HG, Esmaeilian Y, et al. Clinical and molecular features of ovarian stimulation in peripubertal girls with mosaic Turner's syndrome. Hum Reprod. 2026. PMID: 41719147. doi:10.1093/humrep/deag016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。